Motif ID: Tgif1_Meis3
Z-value: 1.756
Transcription factors associated with Tgif1_Meis3:
| Gene Symbol | Entrez ID | Gene Name |
|---|---|---|
| Meis3 | ENSMUSG00000041420.12 | Meis3 |
| Tgif1 | ENSMUSG00000047407.11 | Tgif1 |
Activity-expression correlation:
| Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| Tgif1 | mm10_v2_chr17_-_70853482_70853546 | -0.80 | 5.8e-18 | Click! |
| Meis3 | mm10_v2_chr7_+_16175275_16175438 | -0.40 | 2.8e-04 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 11.5 | 46.0 | GO:0021564 | glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 5.1 | 20.6 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
| 5.0 | 14.9 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
| 4.7 | 23.4 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 4.6 | 22.8 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
| 4.2 | 20.9 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
| 4.1 | 16.3 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
| 3.9 | 15.4 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
| 3.8 | 49.8 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 3.7 | 14.9 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 3.6 | 10.9 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
| 3.5 | 24.7 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 3.1 | 18.8 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
| 3.0 | 8.9 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 2.9 | 14.3 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 2.8 | 11.0 | GO:0048686 | regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 2.4 | 7.3 | GO:0060667 | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) coronal suture morphogenesis(GO:0060365) squamous basal epithelial stem cell differentiation involved in prostate gland acinus development(GO:0060529) fibroblast growth factor receptor signaling pathway involved in mammary gland specification(GO:0060595) mammary gland bud formation(GO:0060615) branch elongation involved in salivary gland morphogenesis(GO:0060667) mesenchymal cell differentiation involved in lung development(GO:0060915) |
| 2.3 | 6.8 | GO:0007403 | glial cell fate determination(GO:0007403) |
| 2.3 | 2.3 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 2.2 | 26.1 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 2.1 | 6.4 | GO:0044413 | regulation of lung blood pressure(GO:0014916) evasion or tolerance of host defenses by virus(GO:0019049) positive regulation of transforming growth factor beta3 production(GO:0032916) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
| 2.1 | 6.3 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 2.1 | 12.4 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
| 2.1 | 18.5 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
| 2.0 | 6.1 | GO:0043379 | memory T cell differentiation(GO:0043379) negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 1.9 | 7.7 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
| 1.9 | 3.8 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
| 1.9 | 7.6 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 1.8 | 5.4 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
| 1.7 | 8.6 | GO:2000551 | regulation of T-helper 2 cell cytokine production(GO:2000551) positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
| 1.7 | 3.3 | GO:1901228 | positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
| 1.7 | 6.7 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
| 1.6 | 4.9 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 1.6 | 9.7 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 1.6 | 6.4 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
| 1.6 | 7.9 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 1.6 | 4.7 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
| 1.5 | 5.8 | GO:0034436 | glycoprotein transport(GO:0034436) |
| 1.4 | 7.1 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
| 1.4 | 8.4 | GO:0046549 | retinal cone cell development(GO:0046549) |
| 1.4 | 4.2 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
| 1.4 | 1.4 | GO:1901630 | negative regulation of presynaptic membrane organization(GO:1901630) |
| 1.3 | 5.3 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
| 1.3 | 6.6 | GO:1903609 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
| 1.3 | 3.9 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 1.3 | 3.9 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 1.3 | 9.1 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
| 1.3 | 6.4 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
| 1.3 | 5.1 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
| 1.3 | 2.5 | GO:0046110 | xanthine metabolic process(GO:0046110) |
| 1.2 | 3.7 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
| 1.2 | 8.6 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
| 1.2 | 4.9 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 1.2 | 5.9 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
| 1.2 | 5.9 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
| 1.2 | 2.3 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 1.1 | 2.2 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
| 1.1 | 3.4 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) regulation of microglial cell activation(GO:1903978) telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 1.1 | 5.5 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 1.1 | 6.5 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 1.1 | 4.3 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
| 1.1 | 4.3 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 1.1 | 5.3 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 1.1 | 15.0 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
| 1.1 | 6.4 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
| 1.1 | 6.4 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
| 1.1 | 4.2 | GO:0090126 | protein complex assembly involved in synapse maturation(GO:0090126) |
| 1.0 | 7.3 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
| 1.0 | 10.5 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 1.0 | 4.1 | GO:1900533 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 1.0 | 5.0 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
| 1.0 | 4.9 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 1.0 | 2.9 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
| 1.0 | 1.0 | GO:0007521 | muscle cell fate determination(GO:0007521) |
| 1.0 | 5.8 | GO:0019695 | choline metabolic process(GO:0019695) |
| 1.0 | 2.9 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.9 | 2.8 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
| 0.9 | 3.7 | GO:0001550 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 0.9 | 3.7 | GO:1903764 | regulation of potassium ion export across plasma membrane(GO:1903764) |
| 0.9 | 2.7 | GO:0015866 | ADP transport(GO:0015866) |
| 0.9 | 6.3 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
| 0.9 | 6.2 | GO:0019532 | oxalate transport(GO:0019532) |
| 0.9 | 3.5 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.9 | 7.8 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
| 0.9 | 5.2 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 0.8 | 4.2 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 0.8 | 2.5 | GO:0003349 | epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
| 0.8 | 1.6 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) |
| 0.8 | 6.5 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.8 | 4.8 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
| 0.8 | 4.8 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
| 0.8 | 8.8 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.8 | 2.4 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
| 0.8 | 3.9 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.8 | 6.3 | GO:1903207 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
| 0.8 | 1.5 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
| 0.8 | 2.3 | GO:0070459 | prolactin secretion(GO:0070459) |
| 0.8 | 2.3 | GO:0050925 | negative regulation of negative chemotaxis(GO:0050925) |
| 0.8 | 2.3 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) |
| 0.8 | 51.8 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 0.8 | 6.1 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
| 0.8 | 2.3 | GO:0042560 | 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.8 | 0.8 | GO:1902336 | neuropilin signaling pathway(GO:0038189) VEGF-activated neuropilin signaling pathway(GO:0038190) positive regulation of retinal ganglion cell axon guidance(GO:1902336) |
| 0.7 | 3.0 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
| 0.7 | 2.2 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
| 0.7 | 2.2 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) regulation of connective tissue replacement(GO:1905203) |
| 0.7 | 2.1 | GO:1900149 | positive regulation of Schwann cell migration(GO:1900149) |
| 0.7 | 2.1 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
| 0.7 | 2.8 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
| 0.7 | 31.4 | GO:0034605 | cellular response to heat(GO:0034605) |
| 0.7 | 20.9 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
| 0.7 | 2.1 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
| 0.7 | 1.4 | GO:0038091 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
| 0.7 | 3.4 | GO:0090005 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
| 0.7 | 2.1 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
| 0.7 | 4.1 | GO:0098909 | regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
| 0.7 | 3.4 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.7 | 8.2 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
| 0.7 | 2.0 | GO:1903538 | meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
| 0.7 | 4.8 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
| 0.7 | 4.7 | GO:0015862 | uridine transport(GO:0015862) |
| 0.7 | 3.4 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) negative regulation of neutrophil activation(GO:1902564) |
| 0.7 | 0.7 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
| 0.7 | 10.0 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
| 0.7 | 1.3 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.7 | 5.9 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
| 0.7 | 3.3 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
| 0.7 | 5.9 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.6 | 3.9 | GO:0010747 | positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
| 0.6 | 2.6 | GO:0070305 | response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
| 0.6 | 1.9 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
| 0.6 | 1.9 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
| 0.6 | 2.5 | GO:0008078 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) mesodermal cell migration(GO:0008078) |
| 0.6 | 3.2 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.6 | 6.9 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
| 0.6 | 1.9 | GO:0009174 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.6 | 3.7 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
| 0.6 | 1.9 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.6 | 25.0 | GO:0006376 | mRNA splice site selection(GO:0006376) |
| 0.6 | 3.7 | GO:1903056 | positive regulation of lens fiber cell differentiation(GO:1902748) regulation of melanosome organization(GO:1903056) |
| 0.6 | 1.8 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
| 0.6 | 1.8 | GO:0031038 | myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
| 0.6 | 1.8 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
| 0.6 | 3.0 | GO:0046880 | regulation of follicle-stimulating hormone secretion(GO:0046880) follicle-stimulating hormone secretion(GO:0046884) |
| 0.6 | 1.8 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.6 | 9.5 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
| 0.6 | 4.2 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
| 0.6 | 2.9 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.6 | 1.2 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
| 0.6 | 0.6 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.6 | 0.6 | GO:0090004 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 0.6 | 18.6 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
| 0.6 | 2.3 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.6 | 1.1 | GO:0030953 | astral microtubule organization(GO:0030953) |
| 0.6 | 1.7 | GO:1900365 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.6 | 1.1 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
| 0.6 | 8.4 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
| 0.6 | 1.7 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.6 | 3.3 | GO:0010359 | regulation of anion channel activity(GO:0010359) |
| 0.5 | 1.6 | GO:1902277 | negative regulation of pancreatic amylase secretion(GO:1902277) |
| 0.5 | 9.2 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.5 | 5.4 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.5 | 1.6 | GO:0043181 | vacuolar sequestering(GO:0043181) |
| 0.5 | 3.8 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.5 | 0.5 | GO:0071317 | cellular response to isoquinoline alkaloid(GO:0071317) |
| 0.5 | 3.7 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
| 0.5 | 5.8 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.5 | 1.6 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
| 0.5 | 5.3 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
| 0.5 | 4.7 | GO:0071420 | cellular response to histamine(GO:0071420) |
| 0.5 | 1.6 | GO:0042196 | dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
| 0.5 | 2.6 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) |
| 0.5 | 2.0 | GO:0006751 | glutathione catabolic process(GO:0006751) |
| 0.5 | 1.5 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
| 0.5 | 2.0 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) endosome to plasma membrane protein transport(GO:0099638) neurotransmitter receptor transport, endosome to plasma membrane(GO:0099639) |
| 0.5 | 3.5 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
| 0.5 | 3.5 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.5 | 2.5 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.5 | 3.8 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.5 | 7.1 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
| 0.5 | 1.9 | GO:0021856 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) facioacoustic ganglion development(GO:1903375) |
| 0.5 | 3.7 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.5 | 1.4 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
| 0.5 | 1.4 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
| 0.5 | 5.0 | GO:0055015 | ventricular cardiac muscle cell development(GO:0055015) |
| 0.5 | 1.4 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
| 0.5 | 1.4 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) |
| 0.5 | 2.3 | GO:0045332 | phospholipid translocation(GO:0045332) |
| 0.5 | 3.2 | GO:0051036 | regulation of endosome size(GO:0051036) |
| 0.4 | 3.6 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
| 0.4 | 1.3 | GO:1900369 | negative regulation of RNA interference(GO:1900369) |
| 0.4 | 5.3 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
| 0.4 | 0.9 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.4 | 1.8 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.4 | 4.7 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.4 | 1.3 | GO:0070474 | positive regulation of uterine smooth muscle contraction(GO:0070474) |
| 0.4 | 1.3 | GO:0003345 | proepicardium cell migration involved in pericardium morphogenesis(GO:0003345) |
| 0.4 | 2.1 | GO:0021508 | floor plate formation(GO:0021508) floor plate morphogenesis(GO:0033505) |
| 0.4 | 1.3 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
| 0.4 | 1.7 | GO:0099550 | trans-synaptic signalling, modulating synaptic transmission(GO:0099550) |
| 0.4 | 6.6 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
| 0.4 | 3.3 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.4 | 1.7 | GO:0042228 | interleukin-8 biosynthetic process(GO:0042228) |
| 0.4 | 2.1 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
| 0.4 | 0.8 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
| 0.4 | 1.6 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
| 0.4 | 0.8 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
| 0.4 | 2.4 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.4 | 1.2 | GO:0030223 | neutrophil differentiation(GO:0030223) |
| 0.4 | 1.2 | GO:0007525 | somatic muscle development(GO:0007525) |
| 0.4 | 5.6 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.4 | 0.8 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
| 0.4 | 5.5 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
| 0.4 | 1.2 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 0.4 | 0.8 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
| 0.4 | 1.2 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.4 | 1.1 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
| 0.4 | 2.2 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
| 0.4 | 4.5 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.4 | 1.1 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.4 | 2.2 | GO:0070314 | G1 to G0 transition(GO:0070314) |
| 0.4 | 4.3 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
| 0.4 | 0.4 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
| 0.4 | 1.8 | GO:0048254 | snoRNA localization(GO:0048254) |
| 0.4 | 3.2 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
| 0.4 | 1.4 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.3 | 3.1 | GO:0036371 | T-tubule organization(GO:0033292) protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
| 0.3 | 1.7 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
| 0.3 | 0.3 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
| 0.3 | 4.4 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.3 | 1.0 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
| 0.3 | 2.4 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
| 0.3 | 1.4 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
| 0.3 | 1.7 | GO:0097113 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
| 0.3 | 2.0 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
| 0.3 | 1.3 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.3 | 6.0 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.3 | 6.0 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
| 0.3 | 1.3 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
| 0.3 | 2.3 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.3 | 1.6 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
| 0.3 | 1.6 | GO:0070417 | cellular response to cold(GO:0070417) |
| 0.3 | 1.6 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 0.3 | 1.3 | GO:0002327 | immature B cell differentiation(GO:0002327) |
| 0.3 | 0.3 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
| 0.3 | 5.1 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
| 0.3 | 1.9 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 0.3 | 5.0 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
| 0.3 | 4.3 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
| 0.3 | 5.5 | GO:0031167 | rRNA methylation(GO:0031167) |
| 0.3 | 2.4 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
| 0.3 | 2.7 | GO:0044144 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
| 0.3 | 1.5 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
| 0.3 | 2.1 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.3 | 1.2 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 0.3 | 5.0 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
| 0.3 | 1.5 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.3 | 1.2 | GO:0015889 | cobalamin transport(GO:0015889) |
| 0.3 | 4.1 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.3 | 2.3 | GO:0006004 | fucose metabolic process(GO:0006004) |
| 0.3 | 3.2 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.3 | 1.7 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
| 0.3 | 0.8 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
| 0.3 | 0.8 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
| 0.3 | 3.1 | GO:2000580 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.3 | 3.4 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
| 0.3 | 0.8 | GO:0010248 | B cell negative selection(GO:0002352) establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 0.3 | 3.3 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 0.3 | 1.4 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
| 0.3 | 16.2 | GO:0003073 | regulation of systemic arterial blood pressure(GO:0003073) |
| 0.3 | 0.5 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 0.3 | 1.1 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.3 | 4.6 | GO:0050909 | sensory perception of taste(GO:0050909) |
| 0.3 | 0.5 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
| 0.3 | 0.5 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
| 0.3 | 1.1 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.3 | 0.5 | GO:0002159 | desmosome assembly(GO:0002159) |
| 0.3 | 0.8 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
| 0.3 | 2.1 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
| 0.3 | 0.8 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
| 0.3 | 21.0 | GO:0030032 | lamellipodium assembly(GO:0030032) |
| 0.3 | 3.1 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.3 | 2.1 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
| 0.3 | 1.0 | GO:0070166 | enamel mineralization(GO:0070166) |
| 0.3 | 4.1 | GO:0042092 | type 2 immune response(GO:0042092) |
| 0.3 | 1.0 | GO:2000858 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) positive regulation of mineralocorticoid secretion(GO:2000857) regulation of aldosterone secretion(GO:2000858) positive regulation of aldosterone secretion(GO:2000860) |
| 0.3 | 1.3 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.3 | 0.8 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
| 0.2 | 0.5 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
| 0.2 | 0.5 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.2 | 1.5 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
| 0.2 | 1.5 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.2 | 4.3 | GO:0006491 | N-glycan processing(GO:0006491) |
| 0.2 | 0.5 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
| 0.2 | 3.8 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
| 0.2 | 0.5 | GO:0001803 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
| 0.2 | 1.9 | GO:0090166 | Golgi disassembly(GO:0090166) |
| 0.2 | 0.5 | GO:0008228 | opsonization(GO:0008228) |
| 0.2 | 4.5 | GO:0097120 | receptor localization to synapse(GO:0097120) |
| 0.2 | 1.2 | GO:0036337 | Fas signaling pathway(GO:0036337) |
| 0.2 | 1.2 | GO:0051775 | response to redox state(GO:0051775) |
| 0.2 | 3.5 | GO:0019835 | cytolysis(GO:0019835) |
| 0.2 | 0.9 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
| 0.2 | 0.7 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
| 0.2 | 0.9 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
| 0.2 | 1.1 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
| 0.2 | 1.4 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
| 0.2 | 0.7 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
| 0.2 | 2.5 | GO:0045176 | apical protein localization(GO:0045176) |
| 0.2 | 0.7 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.2 | 2.9 | GO:0070842 | aggresome assembly(GO:0070842) |
| 0.2 | 0.7 | GO:0010896 | negative regulation of sequestering of triglyceride(GO:0010891) regulation of triglyceride catabolic process(GO:0010896) positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.2 | 1.1 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.2 | 2.0 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
| 0.2 | 0.4 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.2 | 0.7 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
| 0.2 | 5.2 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.2 | 1.1 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
| 0.2 | 1.5 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
| 0.2 | 1.1 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
| 0.2 | 1.9 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.2 | 21.5 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
| 0.2 | 1.9 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.2 | 1.3 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
| 0.2 | 2.9 | GO:0035640 | exploration behavior(GO:0035640) |
| 0.2 | 3.7 | GO:0006308 | DNA catabolic process(GO:0006308) |
| 0.2 | 0.4 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
| 0.2 | 0.4 | GO:0015867 | ATP transport(GO:0015867) |
| 0.2 | 1.2 | GO:0090630 | activation of GTPase activity(GO:0090630) |
| 0.2 | 4.0 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
| 0.2 | 0.8 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
| 0.2 | 1.6 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.2 | 1.0 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
| 0.2 | 1.0 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 0.2 | 6.2 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.2 | 0.6 | GO:0048539 | bone marrow development(GO:0048539) |
| 0.2 | 0.6 | GO:0006097 | glyoxylate cycle(GO:0006097) |
| 0.2 | 2.3 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
| 0.2 | 0.6 | GO:0046381 | CMP-N-acetylneuraminate metabolic process(GO:0046381) |
| 0.2 | 3.4 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
| 0.2 | 1.1 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 0.2 | 1.1 | GO:0006983 | ER overload response(GO:0006983) |
| 0.2 | 0.7 | GO:0006848 | pyruvate transport(GO:0006848) |
| 0.2 | 1.1 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 0.2 | 0.5 | GO:0061724 | lipophagy(GO:0061724) |
| 0.2 | 0.4 | GO:1904417 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
| 0.2 | 2.2 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
| 0.2 | 4.3 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
| 0.2 | 1.2 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
| 0.2 | 0.4 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.2 | 0.7 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.2 | 8.7 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.2 | 0.2 | GO:0060266 | regulation of respiratory burst involved in inflammatory response(GO:0060264) negative regulation of respiratory burst involved in inflammatory response(GO:0060266) negative regulation of respiratory burst(GO:0060268) |
| 0.2 | 1.6 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.2 | 1.0 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
| 0.2 | 0.5 | GO:0071544 | diphosphoinositol polyphosphate catabolic process(GO:0071544) |
| 0.2 | 2.0 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 0.2 | 4.7 | GO:0061157 | mRNA destabilization(GO:0061157) |
| 0.2 | 1.5 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
| 0.2 | 3.2 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.2 | 2.5 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.2 | 0.2 | GO:1902548 | negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
| 0.2 | 0.7 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
| 0.2 | 1.1 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.2 | 1.5 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
| 0.2 | 0.2 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
| 0.2 | 0.6 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
| 0.2 | 3.1 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
| 0.2 | 0.8 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
| 0.2 | 2.6 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.2 | 2.5 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
| 0.2 | 0.3 | GO:0032914 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.2 | 1.3 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.2 | 0.8 | GO:0033572 | transferrin transport(GO:0033572) |
| 0.2 | 2.4 | GO:0097178 | ruffle assembly(GO:0097178) |
| 0.2 | 0.6 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
| 0.2 | 0.8 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
| 0.2 | 1.1 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.2 | 1.4 | GO:0015809 | arginine transport(GO:0015809) |
| 0.2 | 0.5 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.2 | 1.2 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 0.1 | 1.3 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.1 | 4.9 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
| 0.1 | 0.4 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
| 0.1 | 0.9 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.1 | 0.7 | GO:0070494 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
| 0.1 | 0.9 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
| 0.1 | 2.2 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
| 0.1 | 6.5 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
| 0.1 | 0.9 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.1 | 0.6 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.1 | 0.4 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
| 0.1 | 2.4 | GO:0008340 | determination of adult lifespan(GO:0008340) |
| 0.1 | 1.0 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.1 | 1.1 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.1 | 2.1 | GO:0008090 | retrograde axonal transport(GO:0008090) |
| 0.1 | 2.1 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.1 | 1.4 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.1 | 1.0 | GO:0016584 | nucleosome positioning(GO:0016584) |
| 0.1 | 0.4 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.1 | 0.7 | GO:0048538 | thymus development(GO:0048538) |
| 0.1 | 0.7 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
| 0.1 | 0.8 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.1 | 0.8 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
| 0.1 | 0.4 | GO:0002638 | negative regulation of immunoglobulin production(GO:0002638) |
| 0.1 | 0.4 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
| 0.1 | 0.4 | GO:1903896 | positive regulation of IRE1-mediated unfolded protein response(GO:1903896) positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
| 0.1 | 2.3 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
| 0.1 | 2.6 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.1 | 0.5 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
| 0.1 | 1.3 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
| 0.1 | 0.9 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.1 | 4.6 | GO:0030042 | actin filament depolymerization(GO:0030042) |
| 0.1 | 0.2 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.1 | 0.9 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 0.1 | 0.6 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.1 | 2.0 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
| 0.1 | 0.4 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
| 0.1 | 1.4 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
| 0.1 | 2.9 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.1 | 1.2 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.1 | 0.4 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
| 0.1 | 7.5 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
| 0.1 | 0.6 | GO:0015692 | vanadium ion transport(GO:0015676) lead ion transport(GO:0015692) |
| 0.1 | 0.2 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) chemokine (C-C motif) ligand 2 secretion(GO:0035926) regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
| 0.1 | 0.6 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.1 | 0.3 | GO:0050667 | sulfur amino acid metabolic process(GO:0000096) homocysteine metabolic process(GO:0050667) |
| 0.1 | 1.0 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.1 | 0.7 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.1 | 1.1 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.1 | 3.6 | GO:0007032 | endosome organization(GO:0007032) |
| 0.1 | 1.5 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.1 | 1.5 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
| 0.1 | 1.8 | GO:0007041 | lysosomal transport(GO:0007041) |
| 0.1 | 2.8 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
| 0.1 | 1.8 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
| 0.1 | 0.3 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
| 0.1 | 0.1 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
| 0.1 | 0.7 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.1 | 0.6 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
| 0.1 | 0.3 | GO:0090325 | regulation of locomotion involved in locomotory behavior(GO:0090325) negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
| 0.1 | 0.4 | GO:0097298 | regulation of nucleus size(GO:0097298) |
| 0.1 | 1.1 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
| 0.1 | 3.8 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
| 0.1 | 0.3 | GO:1903756 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 0.1 | 0.7 | GO:0010818 | T cell chemotaxis(GO:0010818) |
| 0.1 | 1.9 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
| 0.1 | 0.7 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
| 0.1 | 0.3 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.1 | 0.7 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.1 | 0.7 | GO:0061462 | protein localization to lysosome(GO:0061462) |
| 0.1 | 2.3 | GO:0043113 | receptor clustering(GO:0043113) |
| 0.1 | 1.9 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
| 0.1 | 6.1 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
| 0.1 | 0.6 | GO:0030242 | pexophagy(GO:0030242) |
| 0.1 | 0.3 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
| 0.1 | 4.4 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
| 0.1 | 1.0 | GO:0060117 | auditory receptor cell development(GO:0060117) |
| 0.1 | 0.6 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
| 0.1 | 0.9 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.1 | 0.5 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.1 | 0.8 | GO:0019217 | regulation of fatty acid metabolic process(GO:0019217) |
| 0.1 | 0.3 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
| 0.1 | 0.5 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.1 | 0.4 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
| 0.1 | 0.4 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
| 0.1 | 0.5 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.1 | 1.6 | GO:0007097 | nuclear migration(GO:0007097) establishment of nucleus localization(GO:0040023) |
| 0.1 | 0.2 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
| 0.1 | 1.2 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
| 0.1 | 1.1 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
| 0.1 | 0.2 | GO:0001523 | retinoid metabolic process(GO:0001523) |
| 0.1 | 2.2 | GO:0048286 | lung alveolus development(GO:0048286) |
| 0.1 | 1.2 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
| 0.1 | 0.6 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.1 | 2.6 | GO:0009408 | response to heat(GO:0009408) |
| 0.1 | 0.5 | GO:0006108 | malate metabolic process(GO:0006108) |
| 0.1 | 2.1 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
| 0.1 | 0.9 | GO:0030220 | platelet formation(GO:0030220) platelet morphogenesis(GO:0036344) |
| 0.1 | 0.8 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
| 0.1 | 1.0 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
| 0.1 | 1.3 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
| 0.1 | 0.2 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.1 | 0.6 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
| 0.1 | 0.2 | GO:0018343 | protein farnesylation(GO:0018343) |
| 0.1 | 1.3 | GO:0097352 | autophagosome maturation(GO:0097352) |
| 0.1 | 1.4 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
| 0.1 | 1.2 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.1 | 0.6 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
| 0.1 | 0.7 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.1 | 0.6 | GO:0007567 | parturition(GO:0007567) |
| 0.1 | 0.5 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.1 | 0.7 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
| 0.1 | 0.2 | GO:0046077 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate metabolic process(GO:0009138) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
| 0.1 | 0.4 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.1 | 5.0 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.1 | 0.8 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
| 0.1 | 0.9 | GO:0003016 | respiratory system process(GO:0003016) |
| 0.1 | 0.9 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
| 0.1 | 2.0 | GO:0002381 | immunoglobulin production involved in immunoglobulin mediated immune response(GO:0002381) |
| 0.1 | 0.9 | GO:0035308 | negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
| 0.1 | 0.5 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.1 | 0.5 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.1 | 0.3 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.1 | 0.6 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.1 | 1.1 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
| 0.1 | 1.3 | GO:0050919 | negative chemotaxis(GO:0050919) |
| 0.1 | 0.3 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.1 | 0.9 | GO:0035455 | response to interferon-alpha(GO:0035455) |
| 0.1 | 0.5 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
| 0.1 | 0.2 | GO:0009642 | response to light intensity(GO:0009642) |
| 0.1 | 4.9 | GO:0010977 | negative regulation of neuron projection development(GO:0010977) |
| 0.1 | 0.3 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
| 0.1 | 1.8 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
| 0.1 | 0.5 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.1 | 2.4 | GO:0051453 | regulation of intracellular pH(GO:0051453) |
| 0.1 | 0.6 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
| 0.1 | 1.9 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
| 0.1 | 0.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
| 0.1 | 0.4 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.1 | 3.5 | GO:0007052 | mitotic spindle organization(GO:0007052) |
| 0.1 | 0.2 | GO:0015868 | purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
| 0.1 | 0.5 | GO:0032801 | receptor catabolic process(GO:0032801) |
| 0.1 | 2.0 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.1 | 3.9 | GO:1901800 | positive regulation of proteasomal protein catabolic process(GO:1901800) |
| 0.1 | 1.1 | GO:0007628 | adult walking behavior(GO:0007628) |
| 0.1 | 0.6 | GO:0001569 | patterning of blood vessels(GO:0001569) |
| 0.1 | 0.6 | GO:1903078 | positive regulation of protein localization to plasma membrane(GO:1903078) |
| 0.1 | 0.9 | GO:0034644 | cellular response to UV(GO:0034644) |
| 0.1 | 1.1 | GO:0009303 | rRNA transcription(GO:0009303) |
| 0.1 | 0.4 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
| 0.0 | 0.5 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.0 | 0.4 | GO:0014002 | astrocyte development(GO:0014002) |
| 0.0 | 0.4 | GO:0031274 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
| 0.0 | 0.3 | GO:0072015 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
| 0.0 | 0.1 | GO:1904245 | regulation of polynucleotide adenylyltransferase activity(GO:1904245) |
| 0.0 | 0.8 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
| 0.0 | 0.3 | GO:0006826 | iron ion transport(GO:0006826) |
| 0.0 | 0.5 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
| 0.0 | 0.1 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) |
| 0.0 | 0.4 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
| 0.0 | 0.3 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
| 0.0 | 2.0 | GO:0017157 | regulation of exocytosis(GO:0017157) |
| 0.0 | 1.1 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
| 0.0 | 0.1 | GO:0044028 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.0 | 0.3 | GO:0019985 | translesion synthesis(GO:0019985) |
| 0.0 | 0.6 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
| 0.0 | 0.2 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
| 0.0 | 0.4 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
| 0.0 | 0.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.0 | 0.1 | GO:0003180 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
| 0.0 | 1.0 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
| 0.0 | 2.0 | GO:0050806 | positive regulation of synaptic transmission(GO:0050806) |
| 0.0 | 0.2 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
| 0.0 | 0.5 | GO:0034453 | microtubule anchoring(GO:0034453) |
| 0.0 | 2.4 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
| 0.0 | 0.8 | GO:0007020 | microtubule nucleation(GO:0007020) |
| 0.0 | 0.4 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 0.0 | 0.4 | GO:0060444 | branching involved in mammary gland duct morphogenesis(GO:0060444) |
| 0.0 | 1.1 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.0 | 0.1 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
| 0.0 | 0.6 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
| 0.0 | 0.8 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
| 0.0 | 0.1 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.0 | 0.1 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
| 0.0 | 3.6 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.0 | 0.1 | GO:0006490 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.0 | 0.3 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.0 | 0.2 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
| 0.0 | 0.1 | GO:2000744 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.0 | 0.9 | GO:0019915 | lipid storage(GO:0019915) |
| 0.0 | 0.4 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
| 0.0 | 0.3 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
| 0.0 | 1.8 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
| 0.0 | 0.8 | GO:0099643 | neurotransmitter secretion(GO:0007269) presynaptic process involved in chemical synaptic transmission(GO:0099531) signal release from synapse(GO:0099643) |
| 0.0 | 0.3 | GO:0045922 | negative regulation of fatty acid biosynthetic process(GO:0045717) negative regulation of fatty acid metabolic process(GO:0045922) |
| 0.0 | 0.2 | GO:0005980 | polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.0 | 0.1 | GO:0008380 | RNA splicing(GO:0008380) |
| 0.0 | 0.3 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
| 0.0 | 0.7 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.0 | 3.3 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
| 0.0 | 0.9 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.0 | 0.3 | GO:0034629 | cellular protein complex localization(GO:0034629) |
| 0.0 | 0.4 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
| 0.0 | 0.0 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
| 0.0 | 1.7 | GO:0008643 | carbohydrate transport(GO:0008643) |
| 0.0 | 0.0 | GO:0061010 | gall bladder development(GO:0061010) |
| 0.0 | 0.3 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
| 0.0 | 0.0 | GO:0033206 | meiotic cytokinesis(GO:0033206) |
| 0.0 | 0.4 | GO:0034063 | stress granule assembly(GO:0034063) |
| 0.0 | 1.3 | GO:0072659 | protein localization to plasma membrane(GO:0072659) |
| 0.0 | 0.2 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
| 0.0 | 0.3 | GO:0051209 | release of sequestered calcium ion into cytosol(GO:0051209) regulation of sequestering of calcium ion(GO:0051282) negative regulation of sequestering of calcium ion(GO:0051283) |
| 0.0 | 0.4 | GO:0006829 | zinc II ion transport(GO:0006829) |
| 0.0 | 0.0 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 0.0 | 0.0 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.0 | 0.3 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
| 0.0 | 0.1 | GO:0000154 | rRNA modification(GO:0000154) |
| 0.0 | 0.0 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
| 0.0 | 0.5 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
| 0.0 | 0.2 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
| 0.0 | 0.2 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
| 0.0 | 0.6 | GO:0031032 | actomyosin structure organization(GO:0031032) |
| 0.0 | 0.1 | GO:0030819 | positive regulation of cAMP metabolic process(GO:0030816) positive regulation of cAMP biosynthetic process(GO:0030819) |
| 0.0 | 0.0 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.8 | 17.5 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 4.2 | 12.7 | GO:0072534 | perineuronal net(GO:0072534) |
| 3.6 | 57.6 | GO:0005614 | interstitial matrix(GO:0005614) |
| 3.3 | 16.6 | GO:0044316 | cone cell pedicle(GO:0044316) |
| 3.2 | 9.5 | GO:1990257 | piccolo-bassoon transport vesicle(GO:1990257) |
| 2.6 | 10.4 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
| 2.1 | 6.3 | GO:0098835 | presynaptic endocytic zone(GO:0098833) presynaptic endocytic zone membrane(GO:0098835) |
| 1.8 | 46.2 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
| 1.4 | 8.6 | GO:0045179 | apical cortex(GO:0045179) |
| 1.4 | 5.6 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
| 1.3 | 6.4 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 1.3 | 6.4 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 1.2 | 30.7 | GO:0071565 | nBAF complex(GO:0071565) |
| 1.2 | 3.5 | GO:0071953 | elastic fiber(GO:0071953) |
| 1.1 | 1.1 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 1.1 | 4.2 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
| 1.0 | 5.1 | GO:1990037 | Lewy body core(GO:1990037) |
| 1.0 | 3.0 | GO:0043512 | inhibin A complex(GO:0043512) |
| 1.0 | 4.9 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
| 0.9 | 1.9 | GO:0098888 | extrinsic component of presynaptic membrane(GO:0098888) |
| 0.9 | 2.6 | GO:0098855 | HCN channel complex(GO:0098855) |
| 0.8 | 7.5 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.8 | 11.6 | GO:0043083 | synaptic cleft(GO:0043083) |
| 0.8 | 7.2 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.8 | 4.7 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.8 | 13.6 | GO:0032279 | asymmetric synapse(GO:0032279) |
| 0.8 | 4.5 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
| 0.7 | 3.7 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.7 | 11.9 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.7 | 6.6 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
| 0.7 | 5.7 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
| 0.7 | 8.5 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.7 | 9.0 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
| 0.7 | 5.5 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
| 0.7 | 2.0 | GO:0045298 | tubulin complex(GO:0045298) |
| 0.6 | 1.8 | GO:0016939 | kinesin II complex(GO:0016939) |
| 0.6 | 2.4 | GO:0030314 | junctional membrane complex(GO:0030314) |
| 0.6 | 2.9 | GO:0030891 | VCB complex(GO:0030891) |
| 0.6 | 8.6 | GO:0044292 | dendrite terminus(GO:0044292) |
| 0.6 | 4.0 | GO:0005883 | neurofilament(GO:0005883) |
| 0.6 | 1.7 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
| 0.6 | 50.6 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
| 0.5 | 1.6 | GO:0098831 | presynaptic active zone cytoplasmic component(GO:0098831) |
| 0.5 | 1.6 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
| 0.5 | 3.2 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
| 0.5 | 6.4 | GO:0097542 | ciliary tip(GO:0097542) |
| 0.5 | 2.1 | GO:0031673 | H zone(GO:0031673) |
| 0.5 | 6.4 | GO:0097449 | astrocyte projection(GO:0097449) |
| 0.5 | 9.3 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
| 0.5 | 4.8 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.5 | 63.3 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
| 0.5 | 2.8 | GO:0071439 | clathrin complex(GO:0071439) |
| 0.5 | 2.8 | GO:0005955 | calcineurin complex(GO:0005955) |
| 0.5 | 3.7 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.5 | 5.1 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
| 0.5 | 1.4 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 0.5 | 5.9 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.5 | 3.2 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 0.4 | 3.1 | GO:0070695 | FHF complex(GO:0070695) |
| 0.4 | 1.7 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.4 | 1.7 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 0.4 | 1.3 | GO:0034657 | GID complex(GO:0034657) |
| 0.4 | 2.9 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.4 | 0.4 | GO:0061574 | ASAP complex(GO:0061574) |
| 0.4 | 1.6 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
| 0.4 | 5.1 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.4 | 4.7 | GO:0031430 | M band(GO:0031430) |
| 0.4 | 8.8 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.4 | 4.5 | GO:0098845 | postsynaptic endosome(GO:0098845) |
| 0.4 | 1.5 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
| 0.4 | 4.4 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 0.4 | 4.3 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 0.3 | 2.4 | GO:0005638 | lamin filament(GO:0005638) |
| 0.3 | 0.3 | GO:0099524 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
| 0.3 | 1.4 | GO:0097441 | basilar dendrite(GO:0097441) |
| 0.3 | 1.0 | GO:1903095 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
| 0.3 | 3.6 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.3 | 3.5 | GO:0032426 | stereocilium tip(GO:0032426) |
| 0.3 | 6.3 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
| 0.3 | 4.7 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
| 0.3 | 5.7 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.3 | 86.7 | GO:0045211 | postsynaptic membrane(GO:0045211) |
| 0.3 | 2.8 | GO:0000439 | core TFIIH complex(GO:0000439) |
| 0.3 | 2.2 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
| 0.3 | 1.2 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 0.3 | 1.2 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 0.3 | 1.8 | GO:0034448 | EGO complex(GO:0034448) |
| 0.3 | 0.9 | GO:0044308 | axonal spine(GO:0044308) |
| 0.3 | 4.0 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.3 | 2.5 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.3 | 19.0 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.3 | 4.1 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.3 | 0.8 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.3 | 2.1 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.3 | 1.3 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
| 0.3 | 2.5 | GO:0070545 | PeBoW complex(GO:0070545) |
| 0.3 | 1.0 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
| 0.3 | 2.0 | GO:0033269 | internode region of axon(GO:0033269) |
| 0.3 | 0.8 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
| 0.2 | 2.2 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
| 0.2 | 1.2 | GO:0005726 | perichromatin fibrils(GO:0005726) |
| 0.2 | 1.9 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
| 0.2 | 2.6 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
| 0.2 | 2.1 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.2 | 0.9 | GO:0001652 | granular component(GO:0001652) |
| 0.2 | 1.6 | GO:0030057 | desmosome(GO:0030057) |
| 0.2 | 5.1 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
| 0.2 | 1.3 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.2 | 3.1 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.2 | 1.3 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.2 | 3.3 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 0.2 | 4.2 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.2 | 1.9 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.2 | 1.2 | GO:0005916 | fascia adherens(GO:0005916) |
| 0.2 | 1.2 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
| 0.2 | 5.6 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 0.2 | 9.0 | GO:0044291 | cell-cell contact zone(GO:0044291) |
| 0.2 | 18.1 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
| 0.2 | 1.8 | GO:0032432 | actin filament bundle(GO:0032432) |
| 0.2 | 1.1 | GO:0016342 | catenin complex(GO:0016342) |
| 0.2 | 3.1 | GO:0097228 | sperm principal piece(GO:0097228) |
| 0.2 | 0.7 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
| 0.2 | 0.5 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
| 0.2 | 0.7 | GO:0032009 | early phagosome(GO:0032009) |
| 0.2 | 2.3 | GO:0043196 | varicosity(GO:0043196) |
| 0.2 | 18.1 | GO:0016605 | PML body(GO:0016605) |
| 0.2 | 1.7 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.2 | 2.4 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
| 0.2 | 1.9 | GO:0034464 | BBSome(GO:0034464) |
| 0.2 | 2.3 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.2 | 3.7 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.2 | 0.9 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
| 0.2 | 0.5 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
| 0.2 | 4.5 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.1 | 3.0 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.1 | 2.1 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 0.1 | 2.2 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
| 0.1 | 1.3 | GO:0002177 | manchette(GO:0002177) |
| 0.1 | 1.2 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
| 0.1 | 0.4 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 0.1 | 6.1 | GO:0044306 | neuron projection terminus(GO:0044306) |
| 0.1 | 0.6 | GO:0097447 | dendritic tree(GO:0097447) |
| 0.1 | 0.7 | GO:0005921 | gap junction(GO:0005921) |
| 0.1 | 0.7 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.1 | 0.4 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
| 0.1 | 0.5 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
| 0.1 | 5.2 | GO:0009925 | basal plasma membrane(GO:0009925) |
| 0.1 | 1.3 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.1 | 0.4 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
| 0.1 | 1.8 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 0.1 | 0.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.1 | 0.6 | GO:0070826 | paraferritin complex(GO:0070826) |
| 0.1 | 4.6 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.1 | 2.0 | GO:0035861 | site of double-strand break(GO:0035861) |
| 0.1 | 1.3 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
| 0.1 | 2.0 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.1 | 0.5 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.1 | 22.1 | GO:0005802 | trans-Golgi network(GO:0005802) |
| 0.1 | 2.2 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.1 | 0.7 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 0.1 | 1.8 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 0.1 | 16.1 | GO:0005769 | early endosome(GO:0005769) |
| 0.1 | 0.3 | GO:0014802 | terminal cisterna(GO:0014802) |
| 0.1 | 12.7 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.1 | 0.8 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.1 | 1.1 | GO:0044754 | autolysosome(GO:0044754) |
| 0.1 | 1.9 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
| 0.1 | 0.1 | GO:0001651 | dense fibrillar component(GO:0001651) |
| 0.1 | 0.8 | GO:0030673 | axolemma(GO:0030673) |
| 0.1 | 7.8 | GO:0016363 | nuclear matrix(GO:0016363) |
| 0.1 | 0.7 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.1 | 11.9 | GO:0001650 | fibrillar center(GO:0001650) |
| 0.1 | 0.3 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
| 0.1 | 0.9 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.1 | 13.6 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
| 0.1 | 1.3 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.1 | 0.6 | GO:0071437 | invadopodium(GO:0071437) |
| 0.1 | 3.1 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.1 | 1.0 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.1 | 19.1 | GO:0000139 | Golgi membrane(GO:0000139) |
| 0.1 | 1.1 | GO:0005605 | basal lamina(GO:0005605) |
| 0.1 | 0.5 | GO:0098536 | deuterosome(GO:0098536) |
| 0.1 | 4.2 | GO:0070382 | exocytic vesicle(GO:0070382) |
| 0.1 | 0.6 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
| 0.1 | 0.8 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.1 | 0.8 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.1 | 0.3 | GO:0031045 | dense core granule(GO:0031045) |
| 0.1 | 2.7 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.1 | 0.3 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.1 | 0.2 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
| 0.1 | 6.4 | GO:0030424 | axon(GO:0030424) |
| 0.1 | 0.7 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.1 | 0.3 | GO:0031091 | platelet alpha granule(GO:0031091) |
| 0.1 | 0.7 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.1 | 0.3 | GO:0005827 | polar microtubule(GO:0005827) |
| 0.1 | 1.1 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.1 | 0.4 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
| 0.1 | 1.0 | GO:0036038 | MKS complex(GO:0036038) |
| 0.1 | 28.8 | GO:0009986 | cell surface(GO:0009986) |
| 0.1 | 0.9 | GO:0000145 | exocyst(GO:0000145) |
| 0.1 | 0.6 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 0.1 | 0.7 | GO:0097539 | ciliary transition fiber(GO:0097539) |
| 0.1 | 0.3 | GO:0097386 | glial cell projection(GO:0097386) |
| 0.1 | 0.5 | GO:0031415 | NatA complex(GO:0031415) |
| 0.1 | 1.8 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
| 0.1 | 0.4 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
| 0.1 | 0.3 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
| 0.1 | 1.8 | GO:0005923 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
| 0.1 | 2.3 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.1 | 2.1 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
| 0.1 | 0.3 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
| 0.1 | 5.1 | GO:0030427 | site of polarized growth(GO:0030427) |
| 0.1 | 1.9 | GO:0043204 | perikaryon(GO:0043204) |
| 0.0 | 0.7 | GO:0030315 | T-tubule(GO:0030315) |
| 0.0 | 0.9 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.0 | 1.3 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.0 | 13.9 | GO:0005768 | endosome(GO:0005768) |
| 0.0 | 0.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.0 | 0.7 | GO:0034399 | nuclear periphery(GO:0034399) |
| 0.0 | 0.6 | GO:0016235 | aggresome(GO:0016235) |
| 0.0 | 0.1 | GO:0031251 | PAN complex(GO:0031251) |
| 0.0 | 0.4 | GO:0042405 | nuclear inclusion body(GO:0042405) |
| 0.0 | 0.2 | GO:1904949 | ATPase complex(GO:1904949) |
| 0.0 | 0.5 | GO:0005901 | caveola(GO:0005901) |
| 0.0 | 0.8 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.0 | 0.7 | GO:0032040 | small-subunit processome(GO:0032040) |
| 0.0 | 73.2 | GO:0016021 | integral component of membrane(GO:0016021) |
| 0.0 | 0.8 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
| 0.0 | 0.4 | GO:0000124 | SAGA complex(GO:0000124) |
| 0.0 | 0.2 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 0.0 | 0.1 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.0 | 0.3 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.0 | 1.1 | GO:0030017 | sarcomere(GO:0030017) |
| 0.0 | 0.2 | GO:0016234 | inclusion body(GO:0016234) |
| 0.0 | 0.2 | GO:0038201 | TORC2 complex(GO:0031932) TOR complex(GO:0038201) |
| 0.0 | 0.2 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
| 0.0 | 0.1 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 0.0 | 1.3 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.1 | 16.3 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 3.5 | 10.6 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
| 3.5 | 10.4 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) |
| 3.3 | 19.6 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 3.1 | 21.4 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 2.7 | 8.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 2.6 | 10.2 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
| 2.5 | 7.4 | GO:0043758 | acetate-CoA ligase (ADP-forming) activity(GO:0043758) |
| 2.3 | 7.0 | GO:0008527 | taste receptor activity(GO:0008527) |
| 2.2 | 8.6 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
| 2.1 | 6.4 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
| 2.1 | 6.3 | GO:0002153 | steroid receptor RNA activator RNA binding(GO:0002153) |
| 2.1 | 6.2 | GO:0016160 | alpha-amylase activity(GO:0004556) amylase activity(GO:0016160) |
| 2.0 | 10.2 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
| 2.0 | 11.8 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 1.8 | 10.6 | GO:0045545 | syndecan binding(GO:0045545) |
| 1.7 | 69.5 | GO:0030552 | cAMP binding(GO:0030552) |
| 1.6 | 9.7 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 1.6 | 13.0 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
| 1.6 | 7.9 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
| 1.5 | 56.6 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 1.4 | 10.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
| 1.4 | 4.3 | GO:0034437 | very-low-density lipoprotein particle binding(GO:0034189) glycoprotein transporter activity(GO:0034437) |
| 1.4 | 5.6 | GO:0031720 | haptoglobin binding(GO:0031720) |
| 1.4 | 4.2 | GO:0070890 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
| 1.4 | 6.8 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
| 1.3 | 6.6 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
| 1.3 | 5.3 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 1.3 | 6.4 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
| 1.3 | 3.8 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
| 1.2 | 6.0 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 1.2 | 3.5 | GO:0015228 | coenzyme A transmembrane transporter activity(GO:0015228) adenosine 3',5'-bisphosphate transmembrane transporter activity(GO:0071077) AMP transmembrane transporter activity(GO:0080122) |
| 1.2 | 9.3 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
| 1.2 | 3.5 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
| 1.2 | 25.4 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
| 1.1 | 7.9 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 1.1 | 1.1 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 1.1 | 4.4 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
| 1.1 | 12.9 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 1.0 | 25.8 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 1.0 | 4.1 | GO:0004104 | cholinesterase activity(GO:0004104) choline binding(GO:0033265) |
| 1.0 | 2.9 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
| 1.0 | 8.6 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
| 1.0 | 2.9 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
| 0.9 | 3.7 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.9 | 3.5 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
| 0.8 | 5.9 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.8 | 4.2 | GO:0050816 | phosphothreonine binding(GO:0050816) |
| 0.8 | 1.6 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
| 0.8 | 6.4 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
| 0.8 | 27.9 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.8 | 4.8 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
| 0.8 | 4.7 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
| 0.8 | 2.4 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
| 0.8 | 4.7 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 0.8 | 3.1 | GO:0019808 | polyamine binding(GO:0019808) |
| 0.8 | 5.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 0.8 | 2.3 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
| 0.8 | 2.3 | GO:0005119 | smoothened binding(GO:0005119) hedgehog receptor activity(GO:0008158) |
| 0.8 | 2.3 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
| 0.8 | 8.3 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
| 0.7 | 8.2 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.7 | 5.9 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
| 0.7 | 5.1 | GO:0099609 | microtubule lateral binding(GO:0099609) |
| 0.7 | 4.3 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
| 0.7 | 2.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.7 | 8.3 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
| 0.7 | 2.1 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
| 0.6 | 12.3 | GO:0035198 | miRNA binding(GO:0035198) |
| 0.6 | 2.6 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
| 0.6 | 1.9 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
| 0.6 | 12.7 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
| 0.6 | 1.9 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 0.6 | 5.1 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
| 0.6 | 2.5 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 0.6 | 1.9 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 0.6 | 2.5 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.6 | 3.1 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 0.6 | 2.4 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
| 0.6 | 2.4 | GO:0004441 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) |
| 0.6 | 2.4 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.6 | 4.2 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
| 0.6 | 5.2 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
| 0.6 | 1.7 | GO:0001160 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
| 0.6 | 6.2 | GO:0019531 | secondary active sulfate transmembrane transporter activity(GO:0008271) oxalate transmembrane transporter activity(GO:0019531) |
| 0.6 | 2.2 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 0.6 | 3.3 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
| 0.6 | 2.2 | GO:0030151 | molybdenum ion binding(GO:0030151) |
| 0.5 | 1.6 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
| 0.5 | 1.6 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
| 0.5 | 1.6 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.5 | 4.8 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 0.5 | 2.6 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.5 | 3.2 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.5 | 2.1 | GO:0050347 | trans-hexaprenyltranstransferase activity(GO:0000010) trans-octaprenyltranstransferase activity(GO:0050347) |
| 0.5 | 2.1 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 0.5 | 1.6 | GO:0019120 | hydrolase activity, acting on acid halide bonds(GO:0016824) hydrolase activity, acting on acid halide bonds, in C-halide compounds(GO:0019120) alkylhalidase activity(GO:0047651) |
| 0.5 | 5.1 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
| 0.5 | 8.7 | GO:0046625 | sphingolipid binding(GO:0046625) |
| 0.5 | 3.0 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
| 0.5 | 1.5 | GO:0003796 | lysozyme activity(GO:0003796) |
| 0.5 | 5.0 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.5 | 3.0 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 0.5 | 3.0 | GO:0070699 | type II activin receptor binding(GO:0070699) |
| 0.5 | 7.8 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 0.5 | 7.8 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.5 | 1.0 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.5 | 0.5 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
| 0.5 | 3.7 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 0.5 | 10.4 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.4 | 4.9 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 0.4 | 25.4 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
| 0.4 | 1.3 | GO:0003692 | left-handed Z-DNA binding(GO:0003692) |
| 0.4 | 0.4 | GO:0031687 | A2A adenosine receptor binding(GO:0031687) |
| 0.4 | 4.7 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.4 | 2.1 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
| 0.4 | 6.9 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.4 | 1.3 | GO:0051425 | PTB domain binding(GO:0051425) |
| 0.4 | 4.2 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.4 | 1.3 | GO:0016748 | succinyltransferase activity(GO:0016748) |
| 0.4 | 3.7 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
| 0.4 | 7.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.4 | 1.6 | GO:0035877 | death effector domain binding(GO:0035877) |
| 0.4 | 1.6 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.4 | 2.0 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
| 0.4 | 2.0 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
| 0.4 | 2.8 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 0.4 | 9.2 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
| 0.4 | 1.6 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.4 | 21.0 | GO:0036002 | pre-mRNA binding(GO:0036002) |
| 0.4 | 11.4 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.4 | 2.3 | GO:0035586 | purinergic receptor activity(GO:0035586) |
| 0.4 | 1.2 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 0.4 | 0.8 | GO:0038025 | reelin receptor activity(GO:0038025) |
| 0.4 | 0.4 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
| 0.4 | 17.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.4 | 1.1 | GO:0004875 | complement receptor activity(GO:0004875) |
| 0.4 | 1.9 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
| 0.4 | 7.8 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.4 | 3.7 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
| 0.4 | 41.4 | GO:0008201 | heparin binding(GO:0008201) |
| 0.4 | 4.8 | GO:1990459 | transferrin receptor binding(GO:1990459) |
| 0.4 | 6.2 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.4 | 4.2 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 0.3 | 1.4 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
| 0.3 | 1.4 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
| 0.3 | 2.4 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
| 0.3 | 4.1 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
| 0.3 | 2.8 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.3 | 4.1 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
| 0.3 | 0.7 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
| 0.3 | 20.3 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
| 0.3 | 2.7 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.3 | 1.7 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
| 0.3 | 2.0 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 0.3 | 12.4 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
| 0.3 | 1.7 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.3 | 3.5 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.3 | 3.8 | GO:0015248 | sterol transporter activity(GO:0015248) |
| 0.3 | 0.9 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.3 | 0.3 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
| 0.3 | 4.6 | GO:0005537 | mannose binding(GO:0005537) |
| 0.3 | 17.3 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
| 0.3 | 1.5 | GO:0070330 | aromatase activity(GO:0070330) |
| 0.3 | 4.2 | GO:0031005 | filamin binding(GO:0031005) |
| 0.3 | 1.7 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
| 0.3 | 5.5 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
| 0.3 | 0.9 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
| 0.3 | 4.0 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.3 | 2.2 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.3 | 2.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.3 | 2.4 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
| 0.3 | 0.8 | GO:0042610 | CD8 receptor binding(GO:0042610) |
| 0.3 | 0.5 | GO:0048156 | tau protein binding(GO:0048156) |
| 0.3 | 0.8 | GO:0004998 | transferrin receptor activity(GO:0004998) |
| 0.3 | 2.9 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
| 0.3 | 7.5 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.3 | 0.8 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
| 0.3 | 1.8 | GO:0005536 | glucose binding(GO:0005536) |
| 0.3 | 1.8 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
| 0.3 | 1.0 | GO:0036033 | mediator complex binding(GO:0036033) |
| 0.3 | 1.0 | GO:0034481 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) chondroitin sulfotransferase activity(GO:0034481) |
| 0.2 | 8.2 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.2 | 3.7 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.2 | 1.0 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
| 0.2 | 1.2 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.2 | 4.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.2 | 3.9 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 0.2 | 1.4 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
| 0.2 | 1.4 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.2 | 0.7 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
| 0.2 | 16.2 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
| 0.2 | 2.1 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
| 0.2 | 0.9 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
| 0.2 | 1.8 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.2 | 0.7 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
| 0.2 | 0.9 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 0.2 | 1.3 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
| 0.2 | 0.6 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
| 0.2 | 1.1 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.2 | 1.7 | GO:0048018 | receptor agonist activity(GO:0048018) |
| 0.2 | 0.6 | GO:0017057 | glucose-6-phosphate dehydrogenase activity(GO:0004345) 6-phosphogluconolactonase activity(GO:0017057) |
| 0.2 | 7.9 | GO:0015485 | cholesterol binding(GO:0015485) |
| 0.2 | 1.0 | GO:0009384 | N-acylmannosamine kinase activity(GO:0009384) |
| 0.2 | 0.8 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
| 0.2 | 3.6 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.2 | 6.0 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.2 | 0.6 | GO:0089720 | caspase binding(GO:0089720) |
| 0.2 | 0.6 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 0.2 | 0.8 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
| 0.2 | 7.6 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
| 0.2 | 4.6 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
| 0.2 | 0.6 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
| 0.2 | 0.6 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
| 0.2 | 0.9 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.2 | 1.3 | GO:0045499 | chemorepellent activity(GO:0045499) |
| 0.2 | 2.3 | GO:0051018 | protein kinase A binding(GO:0051018) |
| 0.2 | 8.5 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
| 0.2 | 2.5 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.2 | 0.7 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.2 | 3.7 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 0.2 | 0.7 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 0.2 | 2.3 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.2 | 2.9 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.2 | 1.4 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
| 0.2 | 2.9 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
| 0.2 | 0.5 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
| 0.2 | 1.0 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 0.2 | 1.2 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.2 | 0.8 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
| 0.2 | 4.2 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
| 0.2 | 0.5 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
| 0.2 | 2.3 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
| 0.2 | 1.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 0.2 | 0.6 | GO:0050815 | phosphoserine binding(GO:0050815) |
| 0.2 | 0.8 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 0.2 | 4.8 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.2 | 1.6 | GO:0004622 | lysophospholipase activity(GO:0004622) |
| 0.2 | 3.9 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
| 0.2 | 1.1 | GO:0030911 | TPR domain binding(GO:0030911) |
| 0.2 | 0.6 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.2 | 5.5 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.2 | 1.4 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.2 | 0.6 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
| 0.2 | 2.6 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
| 0.1 | 1.6 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.1 | 2.5 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
| 0.1 | 2.8 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
| 0.1 | 15.1 | GO:0044325 | ion channel binding(GO:0044325) |
| 0.1 | 0.7 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
| 0.1 | 3.6 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.1 | 20.5 | GO:0005516 | calmodulin binding(GO:0005516) |
| 0.1 | 2.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.1 | 2.7 | GO:0042287 | MHC protein binding(GO:0042287) |
| 0.1 | 0.3 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
| 0.1 | 0.5 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 0.1 | 4.6 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
| 0.1 | 1.1 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
| 0.1 | 0.5 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 0.1 | 1.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.1 | 7.5 | GO:0005262 | calcium channel activity(GO:0005262) |
| 0.1 | 1.7 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
| 0.1 | 1.4 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
| 0.1 | 34.6 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.1 | 0.7 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.1 | 1.9 | GO:0070403 | NAD+ binding(GO:0070403) |
| 0.1 | 0.4 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.1 | 0.6 | GO:0015086 | cadmium ion transmembrane transporter activity(GO:0015086) lead ion transmembrane transporter activity(GO:0015094) vanadium ion transmembrane transporter activity(GO:0015100) ferrous iron uptake transmembrane transporter activity(GO:0015639) cadmium ion binding(GO:0046870) |
| 0.1 | 0.9 | GO:0015149 | glucose transmembrane transporter activity(GO:0005355) hexose transmembrane transporter activity(GO:0015149) |
| 0.1 | 0.6 | GO:0071253 | connexin binding(GO:0071253) |
| 0.1 | 2.0 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.1 | 1.3 | GO:0070840 | dynein complex binding(GO:0070840) |
| 0.1 | 2.5 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
| 0.1 | 2.2 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
| 0.1 | 8.7 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
| 0.1 | 0.3 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
| 0.1 | 1.9 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.1 | 0.8 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 0.1 | 0.4 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.1 | 1.3 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
| 0.1 | 1.9 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
| 0.1 | 0.3 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
| 0.1 | 0.6 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
| 0.1 | 0.3 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
| 0.1 | 1.5 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.1 | 0.3 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
| 0.1 | 0.3 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
| 0.1 | 0.5 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
| 0.1 | 1.8 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.1 | 0.4 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
| 0.1 | 0.5 | GO:1990430 | G-protein coupled GABA receptor activity(GO:0004965) extracellular matrix protein binding(GO:1990430) |
| 0.1 | 0.4 | GO:0034056 | estrogen response element binding(GO:0034056) |
| 0.1 | 1.3 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
| 0.1 | 0.4 | GO:0019770 | IgG receptor activity(GO:0019770) |
| 0.1 | 0.1 | GO:0070878 | primary miRNA binding(GO:0070878) |
| 0.1 | 0.6 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
| 0.1 | 0.3 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
| 0.1 | 0.3 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
| 0.1 | 0.5 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
| 0.1 | 2.2 | GO:0032947 | protein complex scaffold(GO:0032947) |
| 0.1 | 0.2 | GO:0004127 | cytidylate kinase activity(GO:0004127) uridylate kinase activity(GO:0009041) |
| 0.1 | 2.5 | GO:0048365 | Rac GTPase binding(GO:0048365) |
| 0.1 | 0.5 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.1 | 0.5 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.1 | 1.3 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.1 | 1.3 | GO:0008374 | O-acyltransferase activity(GO:0008374) |
| 0.1 | 1.1 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
| 0.1 | 2.5 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.1 | 1.4 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 0.1 | 2.6 | GO:0019213 | deacetylase activity(GO:0019213) |
| 0.1 | 0.8 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.1 | 0.1 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
| 0.1 | 0.3 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 0.1 | 0.3 | GO:0015093 | iron ion transmembrane transporter activity(GO:0005381) ferrous iron transmembrane transporter activity(GO:0015093) |
| 0.1 | 6.1 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.1 | 0.3 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
| 0.0 | 0.3 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
| 0.0 | 0.3 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.0 | 0.3 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
| 0.0 | 0.9 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.0 | 1.6 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.0 | 1.1 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.0 | 0.8 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
| 0.0 | 0.5 | GO:0031402 | sodium ion binding(GO:0031402) |
| 0.0 | 0.6 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
| 0.0 | 0.9 | GO:0019894 | kinesin binding(GO:0019894) |
| 0.0 | 0.4 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
| 0.0 | 0.8 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.0 | 0.1 | GO:0001225 | RNA polymerase II transcription cofactor binding(GO:0001224) RNA polymerase II transcription coactivator binding(GO:0001225) |
| 0.0 | 1.2 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
| 0.0 | 0.3 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.0 | 0.5 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
| 0.0 | 0.3 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
| 0.0 | 9.2 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.0 | 0.8 | GO:0015370 | solute:sodium symporter activity(GO:0015370) |
| 0.0 | 0.6 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.0 | 1.3 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.0 | 1.6 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
| 0.0 | 0.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.0 | 1.7 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.0 | 0.5 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 0.0 | 6.1 | GO:0008017 | microtubule binding(GO:0008017) |
| 0.0 | 0.5 | GO:0004527 | exonuclease activity(GO:0004527) |
| 0.0 | 0.1 | GO:0004980 | melanocortin receptor activity(GO:0004977) melanocyte-stimulating hormone receptor activity(GO:0004980) |
| 0.0 | 6.5 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
| 0.0 | 0.5 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 0.0 | 0.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.0 | 0.3 | GO:0042056 | chemoattractant activity(GO:0042056) |
| 0.0 | 1.6 | GO:0005178 | integrin binding(GO:0005178) |
| 0.0 | 0.4 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
| 0.0 | 0.3 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
| 0.0 | 0.2 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.0 | 0.2 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
| 0.0 | 0.8 | GO:0070888 | E-box binding(GO:0070888) |
| 0.0 | 0.1 | GO:0030619 | U1 snRNA binding(GO:0030619) |
| 0.0 | 0.7 | GO:0004519 | endonuclease activity(GO:0004519) |
| 0.0 | 1.1 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
| 0.0 | 0.5 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
| 0.0 | 0.6 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
| 0.0 | 1.2 | GO:0002020 | protease binding(GO:0002020) |
| 0.0 | 0.1 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
| 0.0 | 0.1 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 0.0 | 0.1 | GO:0035591 | signaling adaptor activity(GO:0035591) |
| 0.0 | 0.8 | GO:0016876 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
| 0.0 | 0.3 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.0 | 0.2 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.0 | 0.1 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
| 0.0 | 0.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 0.0 | 0.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.0 | 0.7 | GO:0016879 | ligase activity, forming carbon-nitrogen bonds(GO:0016879) |
| 0.0 | 0.2 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.0 | 0.1 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.7 | 19.6 | PID_INTEGRIN_A9B1_PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.5 | 15.0 | ST_T_CELL_SIGNAL_TRANSDUCTION | T Cell Signal Transduction |
| 0.4 | 24.1 | PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.4 | 13.4 | PID_SHP2_PATHWAY | SHP2 signaling |
| 0.4 | 17.6 | PID_RAS_PATHWAY | Regulation of Ras family activation |
| 0.4 | 14.2 | PID_CDC42_REG_PATHWAY | Regulation of CDC42 activity |
| 0.4 | 2.1 | PID_EPHA2_FWD_PATHWAY | EPHA2 forward signaling |
| 0.3 | 7.2 | PID_PDGFRA_PATHWAY | PDGFR-alpha signaling pathway |
| 0.3 | 20.3 | PID_ERBB1_INTERNALIZATION_PATHWAY | Internalization of ErbB1 |
| 0.3 | 9.7 | PID_ARF_3PATHWAY | Arf1 pathway |
| 0.3 | 41.8 | PID_PDGFRB_PATHWAY | PDGFR-beta signaling pathway |
| 0.3 | 14.7 | PID_REELIN_PATHWAY | Reelin signaling pathway |
| 0.3 | 22.8 | PID_HIF1_TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.3 | 5.7 | PID_LIS1_PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.3 | 10.6 | PID_BMP_PATHWAY | BMP receptor signaling |
| 0.3 | 49.8 | NABA_SECRETED_FACTORS | Genes encoding secreted soluble factors |
| 0.2 | 7.8 | PID_IL4_2PATHWAY | IL4-mediated signaling events |
| 0.2 | 7.3 | PID_FGF_PATHWAY | FGF signaling pathway |
| 0.2 | 10.1 | PID_TAP63_PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.2 | 5.4 | PID_INTEGRIN_A4B1_PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.2 | 10.3 | PID_RHOA_REG_PATHWAY | Regulation of RhoA activity |
| 0.2 | 15.8 | PID_CMYB_PATHWAY | C-MYB transcription factor network |
| 0.2 | 6.2 | PID_VEGFR1_2_PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.2 | 2.6 | PID_HIF1A_PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.2 | 0.8 | PID_VEGF_VEGFR_PATHWAY | VEGF and VEGFR signaling network |
| 0.2 | 3.0 | ST_ERK1_ERK2_MAPK_PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.2 | 2.5 | SA_PROGRAMMED_CELL_DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.2 | 6.2 | PID_HNF3A_PATHWAY | FOXA1 transcription factor network |
| 0.2 | 2.8 | PID_RAC1_REG_PATHWAY | Regulation of RAC1 activity |
| 0.2 | 5.2 | NABA_PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.2 | 3.0 | PID_DNA_PK_PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.1 | 3.2 | PID_PI3KCI_PATHWAY | Class I PI3K signaling events |
| 0.1 | 2.5 | PID_HEDGEHOG_2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.1 | 1.8 | PID_ARF6_DOWNSTREAM_PATHWAY | Arf6 downstream pathway |
| 0.1 | 2.6 | PID_NFKAPPAB_CANONICAL_PATHWAY | Canonical NF-kappaB pathway |
| 0.1 | 1.8 | PID_MET_PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.1 | 1.2 | PID_ECADHERIN_NASCENT_AJ_PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.1 | 0.5 | PID_IL8_CXCR2_PATHWAY | IL8- and CXCR2-mediated signaling events |
| 0.1 | 1.0 | PID_ANGIOPOIETIN_RECEPTOR_PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.1 | 3.0 | PID_REG_GR_PATHWAY | Glucocorticoid receptor regulatory network |
| 0.1 | 1.3 | SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES | Genes related to the insulin receptor pathway |
| 0.1 | 1.1 | PID_P38_MKK3_6PATHWAY | p38 MAPK signaling pathway |
| 0.1 | 1.2 | SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.1 | 1.0 | PID_BARD1_PATHWAY | BARD1 signaling events |
| 0.1 | 0.6 | ST_G_ALPHA_S_PATHWAY | G alpha s Pathway |
| 0.1 | 0.6 | PID_ERBB2_ERBB3_PATHWAY | ErbB2/ErbB3 signaling events |
| 0.0 | 5.7 | NABA_ECM_AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.0 | 0.6 | PID_HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.0 | 0.2 | PID_GMCSF_PATHWAY | GMCSF-mediated signaling events |
| 0.0 | 0.5 | PID_INTEGRIN3_PATHWAY | Beta3 integrin cell surface interactions |
| 0.0 | 0.7 | PID_RXR_VDR_PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.0 | 0.5 | PID_INSULIN_PATHWAY | Insulin Pathway |
| 0.0 | 0.4 | PID_KIT_PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.0 | 0.6 | PID_HNF3B_PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.0 | 0.7 | ST_INTEGRIN_SIGNALING_PATHWAY | Integrin Signaling Pathway |
| 0.0 | 3.0 | NABA_ECM_GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.0 | 0.1 | ST_ADRENERGIC | Adrenergic Pathway |
| 0.0 | 0.4 | PID_HDAC_CLASSII_PATHWAY | Signaling events mediated by HDAC Class II |
| 0.0 | 0.3 | PID_ENDOTHELIN_PATHWAY | Endothelins |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.6 | 22.7 | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 1.6 | 9.5 | REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
| 1.6 | 67.9 | REACTOME_DARPP_32_EVENTS | Genes involved in DARPP-32 events |
| 1.4 | 13.0 | REACTOME_BILE_SALT_AND_ORGANIC_ANION_SLC_TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 1.3 | 17.2 | REACTOME_ACTIVATED_POINT_MUTANTS_OF_FGFR2 | Genes involved in Activated point mutants of FGFR2 |
| 0.8 | 9.9 | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.7 | 3.0 | REACTOME_GLYCOPROTEIN_HORMONES | Genes involved in Glycoprotein hormones |
| 0.7 | 29.7 | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.7 | 6.3 | REACTOME_GAP_JUNCTION_DEGRADATION | Genes involved in Gap junction degradation |
| 0.7 | 26.6 | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.7 | 16.5 | REACTOME_RAS_ACTIVATION_UOPN_CA2_INFUX_THROUGH_NMDA_RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 0.7 | 8.7 | REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.6 | 22.3 | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.6 | 3.7 | REACTOME_COMMON_PATHWAY | Genes involved in Common Pathway |
| 0.6 | 17.3 | REACTOME_RAP1_SIGNALLING | Genes involved in Rap1 signalling |
| 0.6 | 9.9 | REACTOME_GABA_A_RECEPTOR_ACTIVATION | Genes involved in GABA A receptor activation |
| 0.6 | 11.3 | REACTOME_N_GLYCAN_ANTENNAE_ELONGATION | Genes involved in N-Glycan antennae elongation |
| 0.6 | 16.0 | REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
| 0.6 | 7.5 | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.6 | 14.9 | REACTOME_ERK_MAPK_TARGETS | Genes involved in ERK/MAPK targets |
| 0.5 | 5.3 | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 0.5 | 0.5 | REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
| 0.5 | 6.4 | REACTOME_CTNNB1_PHOSPHORYLATION_CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.5 | 13.3 | REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING | Genes involved in DCC mediated attractive signaling |
| 0.5 | 8.1 | REACTOME_HORMONE_SENSITIVE_LIPASE_HSL_MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.5 | 16.5 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.4 | 14.4 | REACTOME_RECYCLING_PATHWAY_OF_L1 | Genes involved in Recycling pathway of L1 |
| 0.4 | 2.9 | REACTOME_ENDOGENOUS_STEROLS | Genes involved in Endogenous sterols |
| 0.4 | 0.8 | REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING | Genes involved in SHC1 events in EGFR signaling |
| 0.4 | 4.6 | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.4 | 2.2 | REACTOME_DSCAM_INTERACTIONS | Genes involved in DSCAM interactions |
| 0.4 | 1.8 | REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
| 0.4 | 19.5 | REACTOME_AMINO_ACID_AND_OLIGOPEPTIDE_SLC_TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
| 0.3 | 1.7 | REACTOME_PLATELET_SENSITIZATION_BY_LDL | Genes involved in Platelet sensitization by LDL |
| 0.3 | 1.4 | REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION | Genes involved in Downstream signal transduction |
| 0.3 | 7.2 | REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 0.3 | 1.3 | REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
| 0.3 | 3.4 | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
| 0.3 | 5.2 | REACTOME_METABOLISM_OF_POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.3 | 7.6 | REACTOME_CGMP_EFFECTS | Genes involved in cGMP effects |
| 0.3 | 6.2 | REACTOME_INSULIN_RECEPTOR_RECYCLING | Genes involved in Insulin receptor recycling |
| 0.3 | 8.5 | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.3 | 6.6 | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.3 | 2.4 | REACTOME_CD28_DEPENDENT_VAV1_PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
| 0.3 | 4.3 | REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
| 0.2 | 5.3 | REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.2 | 9.3 | REACTOME_HS_GAG_BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.2 | 1.9 | REACTOME_MEMBRANE_BINDING_AND_TARGETTING_OF_GAG_PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.2 | 6.7 | REACTOME_L1CAM_INTERACTIONS | Genes involved in L1CAM interactions |
| 0.2 | 8.3 | REACTOME_INHIBITION_OF_VOLTAGE_GATED_CA2_CHANNELS_VIA_GBETA_GAMMA_SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
| 0.2 | 3.0 | REACTOME_NEPHRIN_INTERACTIONS | Genes involved in Nephrin interactions |
| 0.2 | 2.0 | REACTOME_TIE2_SIGNALING | Genes involved in Tie2 Signaling |
| 0.2 | 2.0 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PS | Genes involved in Acyl chain remodelling of PS |
| 0.2 | 2.0 | REACTOME_ACTIVATION_OF_RAC | Genes involved in Activation of Rac |
| 0.2 | 1.7 | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 0.2 | 2.3 | REACTOME_ARMS_MEDIATED_ACTIVATION | Genes involved in ARMS-mediated activation |
| 0.2 | 2.9 | REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.2 | 2.6 | REACTOME_CIRCADIAN_REPRESSION_OF_EXPRESSION_BY_REV_ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
| 0.2 | 4.7 | REACTOME_SYNTHESIS_OF_PC | Genes involved in Synthesis of PC |
| 0.2 | 11.2 | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.2 | 3.2 | REACTOME_PYRUVATE_METABOLISM | Genes involved in Pyruvate metabolism |
| 0.2 | 3.9 | REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.2 | 0.5 | REACTOME_SYNTHESIS_OF_PE | Genes involved in Synthesis of PE |
| 0.2 | 8.4 | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.2 | 1.4 | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 0.2 | 1.2 | REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
| 0.2 | 6.5 | REACTOME_GLYCOLYSIS | Genes involved in Glycolysis |
| 0.2 | 4.1 | REACTOME_SIGNALING_BY_ROBO_RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.2 | 1.2 | REACTOME_NOD1_2_SIGNALING_PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
| 0.2 | 10.8 | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | Genes involved in NRAGE signals death through JNK |
| 0.2 | 4.9 | REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.2 | 1.4 | REACTOME_IL_RECEPTOR_SHC_SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.2 | 2.9 | REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.1 | 1.6 | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
| 0.1 | 6.2 | REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.1 | 14.2 | REACTOME_SIGNALING_BY_RHO_GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.1 | 1.3 | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.1 | 6.0 | REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.1 | 2.0 | REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.1 | 3.2 | REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER | Genes involved in Formation of incision complex in GG-NER |
| 0.1 | 0.6 | REACTOME_FORMATION_OF_TRANSCRIPTION_COUPLED_NER_TC_NER_REPAIR_COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
| 0.1 | 2.5 | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.1 | 3.6 | REACTOME_TRIGLYCERIDE_BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
| 0.1 | 7.0 | REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 0.1 | 2.6 | REACTOME_POTASSIUM_CHANNELS | Genes involved in Potassium Channels |
| 0.1 | 2.1 | REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.1 | 2.6 | REACTOME_MYOGENESIS | Genes involved in Myogenesis |
| 0.1 | 3.1 | REACTOME_GLUTATHIONE_CONJUGATION | Genes involved in Glutathione conjugation |
| 0.1 | 1.3 | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | Genes involved in PKA-mediated phosphorylation of CREB |
| 0.1 | 1.2 | REACTOME_ABACAVIR_TRANSPORT_AND_METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.1 | 4.9 | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.1 | 3.1 | REACTOME_METAL_ION_SLC_TRANSPORTERS | Genes involved in Metal ion SLC transporters |
| 0.1 | 2.8 | REACTOME_SIGNALING_BY_BMP | Genes involved in Signaling by BMP |
| 0.1 | 1.4 | REACTOME_PROTEOLYTIC_CLEAVAGE_OF_SNARE_COMPLEX_PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.1 | 9.7 | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.1 | 2.0 | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.1 | 1.4 | REACTOME_METABOLISM_OF_STEROID_HORMONES_AND_VITAMINS_A_AND_D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
| 0.1 | 2.9 | REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.1 | 1.4 | REACTOME_OXYGEN_DEPENDENT_PROLINE_HYDROXYLATION_OF_HYPOXIA_INDUCIBLE_FACTOR_ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.1 | 1.0 | REACTOME_ACTIVATION_OF_IRF3_IRF7_MEDIATED_BY_TBK1_IKK_EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
| 0.1 | 3.9 | REACTOME_GLUCOSE_TRANSPORT | Genes involved in Glucose transport |
| 0.1 | 4.9 | REACTOME_AMYLOIDS | Genes involved in Amyloids |
| 0.1 | 0.8 | REACTOME_ROLE_OF_DCC_IN_REGULATING_APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.1 | 0.8 | REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
| 0.1 | 1.0 | REACTOME_CALNEXIN_CALRETICULIN_CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 0.1 | 1.7 | REACTOME_REGULATION_OF_WATER_BALANCE_BY_RENAL_AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 0.1 | 4.5 | REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.1 | 2.4 | REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.1 | 0.2 | REACTOME_TRANSLOCATION_OF_ZAP_70_TO_IMMUNOLOGICAL_SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
| 0.1 | 2.7 | REACTOME_NUCLEAR_SIGNALING_BY_ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
| 0.1 | 0.9 | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.1 | 1.6 | REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.1 | 0.9 | REACTOME_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE_TO_CCT_TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
| 0.1 | 1.9 | REACTOME_RNA_POL_III_TRANSCRIPTION_TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
| 0.1 | 1.8 | REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
| 0.1 | 3.3 | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.1 | 0.8 | REACTOME_EGFR_DOWNREGULATION | Genes involved in EGFR downregulation |
| 0.1 | 0.5 | REACTOME_SIGNAL_REGULATORY_PROTEIN_SIRP_FAMILY_INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.1 | 0.8 | REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.0 | 1.7 | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.0 | 1.9 | REACTOME_MEIOTIC_SYNAPSIS | Genes involved in Meiotic Synapsis |
| 0.0 | 0.5 | REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
| 0.0 | 0.7 | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.0 | 0.3 | REACTOME_SIGNALING_BY_PDGF | Genes involved in Signaling by PDGF |
| 0.0 | 2.7 | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
| 0.0 | 0.5 | REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND | Genes involved in Processive synthesis on the lagging strand |
| 0.0 | 0.1 | REACTOME_ADP_SIGNALLING_THROUGH_P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
| 0.0 | 0.2 | REACTOME_CA_DEPENDENT_EVENTS | Genes involved in Ca-dependent events |
| 0.0 | 0.4 | REACTOME_ELONGATION_ARREST_AND_RECOVERY | Genes involved in Elongation arrest and recovery |
| 0.0 | 0.5 | REACTOME_IL1_SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.0 | 0.3 | REACTOME_KERATAN_SULFATE_DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.0 | 0.3 | REACTOME_COPI_MEDIATED_TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.0 | 0.5 | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.0 | 0.4 | REACTOME_REGULATION_OF_RHEB_GTPASE_ACTIVITY_BY_AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.0 | 0.5 | REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.0 | 0.1 | REACTOME_SYNTHESIS_OF_PA | Genes involved in Synthesis of PA |
| 0.0 | 0.2 | REACTOME_GAP_JUNCTION_TRAFFICKING | Genes involved in Gap junction trafficking |
| 0.0 | 0.4 | REACTOME_DOUBLE_STRAND_BREAK_REPAIR | Genes involved in Double-Strand Break Repair |
| 0.0 | 0.5 | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.0 | 0.0 | REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_GLUCAGON_LIKE_PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
|
|
|